Acella Pharmaceuticals, LLC is recalling 190,572 bottles of NP Thyroid (thyroid tablets, USP) in 30 mg, 60 mg, and 90 mg dosages because testing found the tablets to be superpotent, meaning they contain more active ingredient than specified. Taking a higher dose of thyroid hormone than intended can lead to serious health complications. These prescription-only medications were distributed nationwide across the United States and Puerto Rico in 100-count bottles. Consumers should speak with their doctor or pharmacist immediately before making any changes to their medication regimen, as stopping thyroid treatment abruptly can also pose health risks.
The superpotent medication can cause symptoms of hyperthyroidism, including weight loss, heat intolerance, fatigue, muscle weakness, and heart palpitations. In elderly patients or individuals with underlying heart conditions, this excess thyroid hormone can lead to dangerous cardiac issues such as heart failure or irregular heartbeats.
Pharmacy refund for unused medication
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.